These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 29416359

  • 1. Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis.
    Lv L, Li T, Xu K, Shi P, He B, Kong W, Wang J, Sun J.
    Infect Drug Resist; 2018; 11():147-154. PubMed ID: 29416359
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
    Alene KA, Viney K, Yi H, McBryde ES, Yang K, Bai L, Gray DJ, Xu Z, Clements ACA.
    PLoS One; 2018; 13(5):e0197880. PubMed ID: 29791488
    [Abstract] [Full Text] [Related]

  • 3. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A, Gelaw B, Wang SH, Tessema B.
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [Abstract] [Full Text] [Related]

  • 4. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [Abstract] [Full Text] [Related]

  • 5. Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.
    Kurbatova EV, Cegielski JP, Lienhardt C, Akksilp R, Bayona J, Becerra MC, Caoili J, Contreras C, Dalton T, Danilovits M, Demikhova OV, Ershova J, Gammino VM, Gelmanova I, Heilig CM, Jou R, Kazennyy B, Keshavjee S, Kim HJ, Kliiman K, Kvasnovsky C, Leimane V, Mitnick CD, Quelapio I, Riekstina V, Smith SE, Tupasi T, van der Walt M, Vasilyeva IA, Via LE, Viiklepp P, Volchenkov G, Walker AT, Wolfgang M, Yagui M, Zignol M.
    Lancet Respir Med; 2015 Mar; 3(3):201-9. PubMed ID: 25726085
    [Abstract] [Full Text] [Related]

  • 6. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China.
    Liu Q, Lu P, Martinez L, Yang H, Lu W, Ding X, Zhu L.
    BMC Infect Dis; 2018 Mar 06; 18(1):114. PubMed ID: 29510666
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, Lee J.
    Chest; 2000 Mar 06; 117(3):744-51. PubMed ID: 10713001
    [Abstract] [Full Text] [Related]

  • 8. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY, Chen YT, Shu CC, Lee JJ, Wang JY, Yu CJ, Yang PC.
    Chest; 2013 Jun 06; 143(6):1725-1732. PubMed ID: 23288018
    [Abstract] [Full Text] [Related]

  • 9. Sputum smear conversion and treatment outcomes among drug-resistant pulmonary tuberculosis patients in eastern Ethiopia: A 9-years data analysis.
    Gamachu M, Deressa A, Birhanu A, Ayana GM, Raru TB, Negash B, Merga BT, Alemu A, Ahmed F, Mohammed A, Abdulahi IM, Regassa LD.
    Front Med (Lausanne); 2022 Jun 06; 9():1007757. PubMed ID: 36530886
    [Abstract] [Full Text] [Related]

  • 10. Association between Body Mass Index and Sputum Culture Conversion among South Korean Patients with Multidrug Resistant Tuberculosis in a Tuberculosis Referral Hospital.
    Park HO, Kim SH, Moon SH, Byun JH, Kim JW, Lee CE, Kim JD, Jang IS, Yang JH.
    Infect Chemother; 2016 Dec 06; 48(4):317-323. PubMed ID: 27883374
    [Abstract] [Full Text] [Related]

  • 11. Time to Sputum Culture Conversion and Its Predictors Among Multidrug Resistant Tuberculosis Patients in Tigray, Northern Ethiopia: Retrospective Cohort Study.
    Weldemhret L, Atsbaha AH, Bekuretsion H, Desta A, Legesse L, Kahsay AG, Hagos D.
    Infect Drug Resist; 2023 Dec 06; 16():3671-3681. PubMed ID: 37324659
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of time to sputum smear conversion and its association with treatment outcomes among drug-resistant tuberculosis patients: a retrospective record-reviewing study.
    Alzarea AI, Saifullah A, Khan YH, Alanazi AS, Alatawi AD, Algarni MA, Almalki ZS, Alahmari AK, Alhassan HH, Mallhi TH.
    Front Pharmacol; 2024 Dec 06; 15():1370344. PubMed ID: 38898922
    [Abstract] [Full Text] [Related]

  • 13. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM, Sachdeva KS, Dewan PK, Rade K, Nair SA, Pant R, Khaparde SD.
    PLoS One; 2018 Dec 06; 13(4):e0193903. PubMed ID: 29641576
    [Abstract] [Full Text] [Related]

  • 14. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May 06; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 15. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
    Magee MJ, Kempker RR, Kipiani M, Tukvadze N, Howards PP, Narayan KM, Blumberg HM.
    PLoS One; 2014 May 06; 9(4):e94890. PubMed ID: 24736471
    [Abstract] [Full Text] [Related]

  • 16. Models for Predicting Time to Sputum Conversion Among Multi-Drug Resistant Tuberculosis Patients in Lagos, South-West Nigeria.
    Akinsola OJ, Yusuf OB, Ige OM, Okonji PE.
    Front Public Health; 2018 May 06; 6():347. PubMed ID: 30538978
    [Abstract] [Full Text] [Related]

  • 17. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
    Vashistha H, Hanif M, Saini S, Khanna A, Sharma S, Sidiq Z, Ahmed V, Dubey M, Chopra KK, Shrivastava D.
    Indian J Tuberc; 2016 Jul 06; 63(3):144-148. PubMed ID: 27865234
    [Abstract] [Full Text] [Related]

  • 18. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar 06; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 19. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.
    Ann Intern Med; 2006 May 02; 144(9):650-9. PubMed ID: 16670134
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A, Kebede A, Yaregal Z, Dagne Z, Moga S, Yenew B, Diriba G, Molalign H, Tadesse M, Adisse D, Getahun M, Desta K.
    BMC Infect Dis; 2017 Apr 17; 17(1):280. PubMed ID: 28415989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.